GL:NYE-Globe Life Inc (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 109.6

Change

+1.19 (+1.10)%

Market Cap

N/A

Volume

0.64M

Analyst Target

USD 89.17
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
AFL Aflac Incorporated

+0.38 (+0.35%)

USD 61.64B
MET-PA MetLife Inc Preferred Stock Se..

-0.04 (-0.14%)

USD 48.23B
MET-PE MetLife Inc Preferred Stock Se..

-0.09 (-0.36%)

USD 44.41B
PRU Prudential Financial Inc

+0.97 (+0.81%)

USD 43.48B
PUK Prudential Public Limited Comp..

+1.34 (+7.89%)

USD 23.20B
PRI Primerica Inc

+2.29 (+0.87%)

USD 8.74B
JXN Jackson Financial Inc

+0.67 (+0.75%)

USD 6.55B
FG F&G Annuities & Life Inc.

+1.00 (+2.38%)

USD 5.34B
ANG-PA American National Group Inc.

-0.03 (-0.12%)

N/A
MET-PF MetLife Inc Preferred Stock Se..

-0.04 (-0.17%)

N/A

ETFs Containing GL

FLI:CA CI U.S. & Canada Lifeco C.. 7.74 % 0.92 %

+0.09 (+0.61%)

CAD 0.09B
TPLC Timothy Plan US Large/Mid.. 0.95 % 0.00 %

+0.36 (+0.61%)

USD 0.26B
RSPE Invesco Exchange-Traded F.. 0.67 % 0.00 %

+0.35 (+0.61%)

USD 0.01B
2B77:XETRA iShares Ageing Population.. 0.65 % 0.00 %

+0.09 (+0.61%)

USD 0.50B
2B77:F iShares Ageing Population.. 0.65 % 0.00 %

+0.04 (+0.61%)

N/A
XEWE:XETRA Xtrackers S&P 500 Equal W.. 0.43 % 0.00 %

+0.07 (+0.61%)

USD 1.70B
XZEW:XETRA Xtrackers S&P 500 Equal W.. 0.43 % 0.00 %

+0.10 (+0.61%)

USD 1.78B
ISCV iShares Morningstar Small.. 0.43 % 0.00 %

+0.54 (+0.61%)

USD 0.43B
SPED:LSE Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

+0.19 (+0.61%)

USD 0.09B
QUS:AU BetaShares S&P 500 Equal .. 0.25 % 0.00 %

+0.10 (+0.61%)

USD 0.44B
SPEQ:LSE Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

-0.03 (0.61%)

USD 0.37B
XEWG:LSE Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

+0.04 (+0.61%)

USD 0.08B
SP2D:XETRA Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

+0.11 (+0.61%)

USD 0.21B
SP2Q:XETRA Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

-0.15 (0.61%)

USD 0.47B
XDEW:F Xtrackers (IE) Public Lim.. 0.25 % 0.00 %

+0.43 (+0.61%)

USD 7.77B
XDEW:XETRA Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

+0.16 (+0.61%)

USD 2.73B
XDEE:XETRA Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

+0.03 (+0.61%)

USD 8.60B
XDED:XETRA Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

+0.11 (+0.61%)

USD 8.65B
XDEW:SW Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

-0.46 (0.61%)

USD 7.94B
KIE SPDR® S&P Insurance ETF 0.00 % 0.35 %

+0.08 (+0.61%)

N/A
RYF 0.00 % 0.40 %

N/A

N/A
TPLE Timothy Plan - Timothy Pl.. 0.00 % 0.00 %

+0.17 (+0.61%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.96% 11% F 14% F
Dividend Return 0.58% 6% D- 10% F
Total Return -9.38% 11% F 13% F
Trailing 12 Months  
Capital Gain -0.67% 11% F 18% F
Dividend Return 0.84% 6% D- 10% F
Total Return 0.17% 11% F 17% F
Trailing 5 Years  
Capital Gain 13.93% 40% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.93% 33% F 38% F
Average Annual (5 Year Horizon)  
Capital Gain 5.59% 44% F 58% F
Dividend Return 6.48% 39% F 52% F
Total Return 0.88% 6% D- 20% F
Risk Return Profile  
Volatility (Standard Deviation) 16.68% 78% C+ 60% D-
Risk Adjusted Return 38.84% 33% F 56% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.